2024-04-09 08:00 | UU:GALT | | News Release200 | Galectin Therapeutics Reports the Positive Outcome of the Fifth Data and Safety Monitoring Board Meeting for NAVIGATE Phase 2b/3 Study of Belapectin in Patients with Cirrhotic Portal Hypertension Caused by Metabolic Dysfunction-Associated SteatoHepatitis |
2024-03-29 08:00 | UU:GALT | | News Release200 | Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update |
2024-03-12 08:00 | UU:GALT | | News Release200 | Galectin Therapeutics Expands Clinical Team with the Appointment of Khurram Jamil, M.D. as Vice President, Clinical Development |
2023-11-13 08:46 | UU:GALT | | News Release200 | UPDATE ¢ € “ Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update |
2023-11-13 08:00 | UU:GALT | | News Release200 | Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update |
2023-11-03 08:00 | UU:GALT | | News Release200 | Galectin Therapeutics to Share Five Scientific Presentations at The Liver Meeting ¢ „ ¢ 2023, Hosted by the AASLD |
2023-10-23 08:00 | UU:GALT | | News Release200 | Galectin Therapeutics to Participate in the H.C. Wainwright 7th Annual NASH Investor Conference on October 24, 2023 |
2023-10-12 08:00 | UU:GALT | | News Release200 | Galectin Therapeutics Announces Nomination of Dr. Benjamin S. Carson, Sr. to Board of Directors |
2023-10-03 08:00 | UU:GALT | | News Release200 | Galectin Therapeutics Reports the Positive Outcome of the Fourth Data and Safety Monitoring Board Meeting for NAVIGATE, its Seamless, Adaptive Phase 2b/3 Study of Belapectin in Patients with Portal Hypertension Caused by Non-Alcoholic SteatoHepatitis Live |
2023-09-26 08:00 | UU:GALT | | News Release200 | Galectin Therapeutics to Present Update on its Belapectin Liver Cirrhosis Program at the 20th Edition of Discovery on Target meeting, in Boston, September 25-28, 2023 |
2023-09-11 08:00 | UU:GALT | | News Release200 | Galectin Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference on September 13, 2023 |
2023-09-07 12:00 | UU:GALT | | News Release200 | Galectin Therapeutics to Present Data on Liver Cirrhosis at the 9th Edition of the Paris NASH meeting, at Institut Pasteur, September 7th & 8th 2023 |
2023-08-14 08:00 | UU:GALT | | News Release200 | Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2023 and Provides Business Update |
2023-05-15 08:00 | UU:GALT | | News Release200 | Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2023 and Provides Business Update |